Anti-viral guanosine-rich oligonucleotides
US6150339A · kind A · utility
1Cited by
9References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 1997 |
| Grant date | Nov 21, 2000 |
| Priority date | — |
| Expiry date | Dec 9, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and compositions for treating viral infection in vitro and in vivo using a guanosine-rich oligonucleotides. The oligonucleotides have sufficient guanosine to form a guanosine tetrad. They can be composed of at least about 40% guanosine nucleotides. Also provided are oligonucleotides of at least two runs of at least two guanosines. Also provided are guanosine-rich oligonucleotides and methods for treating viral infections in humans, and a method for designing guanosine-rich oligonucleotides having anti-viral activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.